Biomerica (BMRA) Gross Profit Growth (3y) (2013 - 2026)
Biomerica (BMRA) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.15% |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | -33.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -33.26% |
| Nov 30, 2025 | -47.48% |
| Aug 31, 2025 | 113.33% |
| May 31, 2025 | -33.75% |
| Feb 28, 2025 | -77.52% |
| Nov 30, 2024 | -17.27% |
| Aug 31, 2024 | 73.78% |
| May 31, 2024 | 15.72% |
| Feb 29, 2024 | -26.60% |
| Nov 30, 2023 | 1.73% |
| Aug 31, 2023 | 102.95% |
| May 31, 2023 | -65.23% |
| Feb 28, 2023 | -17.28% |
| Nov 30, 2022 | -9.11% |
| Aug 31, 2022 | -29.06% |
| May 31, 2022 | 50.88% |
| Feb 28, 2022 | 65.98% |
| Nov 30, 2021 | 23.67% |
| Aug 31, 2021 | -31.31% |
| May 31, 2021 | -63.63% |